Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeri Kim

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
Oncotarget|December 8, 2017
LINE-1 methylation in peripheral blood leukocytes and clinical characteristics and prognosis of prostate cancer patientsYuyan Han, Junfeng Xu, Jeri Kim, et al.
European Urology Open Science|January 23, 2025
A Cross-sectional Survey of Physicians to Understand Biomarker Testing and Treatment Patterns in Patients with Prostate Cancer in the USA, EU5, Japan, and ChinaChristian Gratzke, Himani Aggarwal, Jeri Kim, et al.
Advances in Therapy|March 22, 2022
Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and JapanAndrea Leith, Jeri Kim, Amanda Ribbands, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2014
The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patientsYonggang He, Jian Gu, Sara Strom, et al.
Future Oncology (London, England)|January 19, 2022
Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and JapanAndrea Leith, Amanda Ribbands, Jeri Kim, et al.
BMC Urology|March 12, 2022
Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and JapanAndrea Leith, Amanda Ribbands, Jeri Kim, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|April 26, 2018
Caffeine intake is not associated with serum testosterone levels in adult men: cross-sectional findings from the NHANES 1999-2004 and 2011-2012David S Lopez, Shailesh Advani, Xueting Qiu, et al.
Current Medicinal Chemistry|December 17, 2016
Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future DirectionsSpyridon P Basourakos, Likun Li, Ana M Aparicio, et al.
Urologic Oncology|April 10, 2003
Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: a phase II studyJeri Kim, Randall E Millikan, Terry L Smith, et al.
BJU International|November 6, 2009
Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour fociJohn W Davis, Jeri Kim, John F Ward, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Oncotarget|December 8, 2017
LINE-1 methylation in peripheral blood leukocytes and clinical characteristics and prognosis of prostate cancer patientsYuyan Han, Junfeng Xu, Jeri Kim, et al.
European Urology Open Science|January 23, 2025
A Cross-sectional Survey of Physicians to Understand Biomarker Testing and Treatment Patterns in Patients with Prostate Cancer in the USA, EU5, Japan, and ChinaChristian Gratzke, Himani Aggarwal, Jeri Kim, et al.
Advances in Therapy|March 22, 2022
Real-World Treatment Patterns in Metastatic Castration-Resistant Prostate Cancer Across Europe (France, Germany, Italy, Spain, and the United Kingdom) and JapanAndrea Leith, Jeri Kim, Amanda Ribbands, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2014
The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patientsYonggang He, Jian Gu, Sara Strom, et al.
Future Oncology (London, England)|January 19, 2022
Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and JapanAndrea Leith, Amanda Ribbands, Jeri Kim, et al.
BMC Urology|March 12, 2022
Impact of next-generation hormonal agents on treatment patterns among patients with metastatic hormone-sensitive prostate cancer: a real-world study from the United States, five European countries and JapanAndrea Leith, Amanda Ribbands, Jeri Kim, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|April 26, 2018
Caffeine intake is not associated with serum testosterone levels in adult men: cross-sectional findings from the NHANES 1999-2004 and 2011-2012David S Lopez, Shailesh Advani, Xueting Qiu, et al.
Current Medicinal Chemistry|December 17, 2016
Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future DirectionsSpyridon P Basourakos, Likun Li, Ana M Aparicio, et al.
Urologic Oncology|April 10, 2003
Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: a phase II studyJeri Kim, Randall E Millikan, Terry L Smith, et al.
BJU International|November 6, 2009
Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour fociJohn W Davis, Jeri Kim, John F Ward, et al.
Pageof 11